· Original article
Woori earnings top KRW 1 trillion as credit costs decline
Woori earnings exceeded KRW 1 trillion in Q3 2026 as credit costs fell, while a narrower bank lending margin tempered stronger nine-month results.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Read the original source and publication date in each article.
Results: 1,794 · Page 13 / 150
· Original article
Woori earnings exceeded KRW 1 trillion in Q3 2026 as credit costs fell, while a narrower bank lending margin tempered stronger nine-month results.
· Original article
Eagle Bancorp earnings rose to $24.2 million in Q3 2026 as provisions fell, while pre-provision revenue declined and nonperforming assets increased.
· Original article
Icelandair earnings improved in Q3 2026 as yields rose 17%, but management still expects a full-year EBITDA loss ahead of a reduced winter schedule.
· Original article
Remibrutinib trials showed lower relapse rates than teriflunomide in relapsing MS. Novartis plans global approval applications after Phase 3 results.
· Original article
Deckers shares fell as much as 6% on October 23 after a fiscal Q2 sales miss and a lower FY27 growth forecast, despite record revenue and higher profit.
· Original article
First Hawaiian earnings show higher Q3 interest income, but loan payoffs prompted a lower 2026 growth forecast. A $24.3 million tax settlement adds a complication.
· Original article
Customers Bancorp earnings show record Q3 2026 deposits and loans, $208 million in net interest income and updated full-year growth guidance.
· Original article
Hubbell dividend rises to $1.52 per share, payable December 15, as management lifts 2026 adjusted EPS guidance with an expected NSI contribution.
· Original article
Sterlite margin target rises to about 30% for FY2029 as data center orders expand, while its INR20,000 crore revenue goal remains unchanged.
· Original article
Ameris earnings reached $116.1 million in Q3 2026 as lending grew and expenses fell, while higher deposit costs and weaker mortgage revenue weighed.
· Original article
Ifetroban trial findings announced by Cumberland on October 23 highlight safety and tolerability in systemic sclerosis, with further research planned.
· Original article
Bloom Energy shares closed at $193.30 on October 23 despite record quarterly revenue, stronger profits and a higher full-year 2026 outlook.
Charts and market data by TradingView. Availability and delays vary by exchange.